A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

August 4, 2021

Study Completion Date

August 26, 2021

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

BAY2586116

Nasal administration

DRUG

Placebo

Matching placebo

Trial Locations (1)

SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka